Skip to main content
Singapore Clinical Research Institute will NEVER ask you to transfer money or disclose bank details over a call.
Singapore Clinical Research Institute (SCRI)

AHCC 04

Find out about the completed Phase II dose escalating trial of intra-tumoral BrachySil in unresectable hepatocellular carcinoma, with results published in a leading oncology journal.

Last updated on 22 June 2026